Tranilast, an NLRP3 inhibitor that is clinically applied as an anti-allergic drug but is less specific than MCC950 [24, 44], is of interest to us because it may have a positive impact on the treatment of endometriosis. The gene discussed is NLRP3; the disease is endometriosis.